Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-017-4404-4
Published Online: 2017-07-27
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilson, Florence R.
Varu, Abhishek
Mitra, Debanjali
Cameron, Chris
Iyer, Shrividya
Funding for this research was provided by:
Pfizer Inc
License valid from 2017-07-27